{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:38:15Z","timestamp":1761863895703,"version":"build-2065373602"},"reference-count":10,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.anai.2018.09.458","type":"journal-article","created":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T21:18:18Z","timestamp":1537478298000},"page":"119-120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Omalizumab as single-dose therapy for vernal keratoconjunctivitis"],"prefix":"10.1016","volume":"122","author":[{"given":"Rachel S.","family":"Simpson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8967-9432","authenticated-orcid":false,"given":"Jason K.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anai.2018.09.458_bib0001","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1001\/jamaophthalmol.2015.5679","article-title":"Omalizumab treatment of vernal keratoconjunctivitis","volume":"134","author":"Heffler","year":"2016","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.anai.2018.09.458_bib0002","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/pai.12737","article-title":"Vernal keratoconjunctivitis treated with omalizumab: a case series","volume":"28","author":"Occasi","year":"2017","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.anai.2018.09.458_bib0003","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jaapos.2012.12.153","article-title":"Severe vernal keratoconjunctivitis successfully treated with subcutaneous omalizumab","volume":"17","author":"De Klerk","year":"2013","journal-title":"J AAPOS"},{"key":"10.1016\/j.anai.2018.09.458_bib0004","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.aller.2011.08.002","article-title":"Omalizumab: an option in vernal keratoconjunctivitis","volume":"40","author":"S\u00e1nchez","year":"2012","journal-title":"Allergol Immunopathol (Madr)"},{"key":"10.1016\/j.anai.2018.09.458_bib0005","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1517\/14712598.5.12.1603","article-title":"Omalizumab: a future innovation for treatment of severe ocular allergy","volume":"5","author":"Williams","year":"2005","journal-title":"Exp Opin Biol Ther"},{"key":"10.1016\/j.anai.2018.09.458_bib0006","doi-asserted-by":"crossref","DOI":"10.1136\/bcr.04.2010.2919","article-title":"Omalizumab for severe atopic keratoconjunctivitis","author":"Taill\u00e9","year":"2010","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.anai.2018.09.458_bib0007","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s40123-016-0074-2","article-title":"Omalizumab in severe refractory vernal keratoconjunctivitis in children: case series and review of the literature","volume":"6","author":"Doan","year":"2017","journal-title":"Ophthalmol Ther"},{"key":"10.1016\/j.anai.2018.09.458_bib0008","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0953-4431(00)00041-2","article-title":"Ocular immune privilege: a review","volume":"12","author":"Koevary","year":"2000","journal-title":"Clin Eye Vis Care"},{"key":"10.1016\/j.anai.2018.09.458_bib0009","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/ACI.0b013e3282efb726","article-title":"Clinical grading of vernal keratoconjunctivitis","volume":"7","author":"Bonini","year":"2007","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2018.09.458_bib0010","first-page":"88","article-title":"Ocular complications of vernal keratoconjunctivitis","volume":"34","author":"Tabbara","year":"1999","journal-title":"Can J Ophthalmol"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120618312055?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120618312055?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:19:06Z","timestamp":1761052746000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120618312055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S1081120618312055"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2018.09.458","relation":{},"ISSN":["1081-1206"],"issn-type":[{"type":"print","value":"1081-1206"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Omalizumab as single-dose therapy for vernal keratoconjunctivitis","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2018.09.458","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}